Application period now closed.

The UCLA Resource Centers for Minority Aging Research Center for Health Improvement of Minority Elderly (RCMAR/CHIME) and CTSI Pilot Project Award provides one-year funding of up to $55,000 for under-represented minority junior- and mid-level faculty and post-doctoral researchers.

Applicants that are funded will conduct a pilot research project that focuses on minority older adult populations. Applicants are required to have a faculty appointment at UCLA or at another academic institution/organization in the greater Los Angeles area. Support will be given to pilot research projects that are consistent with the goal of the RCMAR/CHIME to provide research training and mentoring to under-represented minority junior- and midlevel faculty so they can advance their academic careers by conducting research that contributes to the reduction of health disparities affecting minority elders.

Please read the complete application instructions document and complete the application form to apply. Applications must be submitted by 2 pm Monday, December 4. Please include all requirements listed on Candidates will be notified by December 20, if they have been selected to submit a full proposal.


Past Pilot Project Awardees
View all previously funded projects and awardees
Contact Us
For questions regarding the content, scope, or eligibility of this opportunity


The UCLA Clinical and Translational Science Institute (CTSI) is a research partnership of UCLA, Cedars-Sinai Medical Center, Charles R. Drew University of Medicine and Science and the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. Its mission is to bring biomedical innovations to bear on the greatest health needs of Los Angeles—one of the most ethnically and economically diverse counties in the United States. Our vision is to catalyze research that translates discoveries into tangible improvements in health care, disease prevention and health in our community. The UCLA CTSI is one of more than 50 research hubs supported by the Clinical and Translational Sciences Award (CTSA) program of National Center for Advancing Translational Sciences (NCATS). NCATS—one of 27 Institutes and Centers at the National Institutes of Health (NIH)—was established to transform the translational process so that new treatments and cures for disease can be delivered to patients faster.